Athena Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Sell
795
-232
-23% -$61K 0.13% 126
2026
Q1
$274K Hold
1,027
0.14% 124
2025
Q4
$258K Hold
1,027
0.13% 130
2025
Q3
$295K Sell
1,027
-4
-0.4% -$1.07K 0.15% 124
2025
Q2
$271K Hold
1,031
0.15% 129
2025
Q1
$240K Sell
1,031
-6
-0.6% -$1.46K 0.15% 130
2024
Q4
$238K Sell
1,037
-7
-0.7% -$1.61K 0.14% 134
2024
Q3
$233K Buy
1,044
+4
+0.4% +$879 0.13% 138
2024
Q2
$212K Buy
1,040
+48
+5% +$9.76K 0.13% 142
2024
Q1
$217K Buy
992
+40
+4% +$8.81K 0.13% 140
2023
Q4
$216K Buy
+952
New +$200K 0.14% 135

Other funds holding LH

Athena Investment Management's LH Position: Q2 2026 in Review

Athena Investment Management reduced its Labcorp (LH) stake by 23% in Q2 2026, selling an estimated $61K and leaving 795 shares worth $223K. The position accounts for 0.13% of the portfolio, ranked #126.

Athena Investment Management first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $295K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Athena Investment Management held 795 shares of Labcorp worth $223K as of Q2 2026.
  • Athena Investment Management sold 232 Labcorp shares in Q2 2026, an estimated $61K.
  • Labcorp made up 0.13% of Athena Investment Management's portfolio in Q2 2026, its #126 holding.
  • Athena Investment Management first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Athena Investment Management's Labcorp position peaked at $295K in Q3 2025.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Athena Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.